XCiDaBLE, a phase IV, prospective observational trial evaluating incobotulinumtoxinA (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline data for subjects with blepharospasm

被引：0

作者：

LeDoux, M. S. ^{[1
]}

Jankovic, J. ^{[2
]}

Sethi, K. ^{[3
]}

Verma, A. ^{[3
]}

Pappert, E. J. ^{[3
]}

Fernandez, H. H. ^{[4
]}

机构：

[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] Merz Pharmaceut LLC, Greensboro, NC USA

[4] Cleveland Clin, Cleveland, OH 44106 USA

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：313 / 313

页数：1

共 21 条

[1] XCiDaBLE, a phase IV, observational, prospective trial evaluating incobotulinumtoxin A (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline results for subjects with cervical dystonia
Truong, D.
Danisi, F.
Sethi, K.
Verma, A.
Pappert, E. J.
Fernandez, H. H.
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 667 - 667
[2] XCiDaBLE: Observational, prospective trial evaluating xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the USA
Fernandez, H. H.
Jankovic, J.
Pagan, F.
Greeley, D.
Sethi, K.
Verma, A.
MOVEMENT DISORDERS, 2015, 30 : S508 - S508
[3] XCiDaBLE: A Phase 4, Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Preliminary Baseline Employment History Data
Fernandez, Hubert
Danisi, Fabio
Daniel Truong
Pappert, Eric
Verma, Amit
Sethi, Kapil
Zadikoff, Cindy
NEUROLOGY, 2012, 78
[4] A Prospective, Observational Trial Evaluating Xeomin [IncobotulinumtoxinA] for Cervical Dystonia or Blepharospasm in the US - Preliminary Baseline Results for Patients with Blepharospasm
LeDoux, Mark S.
Jankovic, Joseph
Sethi, Kapil D.
Verma, Amit
Pappert, Eric J.
Fernandez, Hubert H.
ANNALS OF NEUROLOGY, 2012, 72 : S102 - S103
[5] XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm in the United States - Preliminary baseline results for patients with blepharospasm
LeDoux, M. S.
Jankovic, J. J.
Sethi, K.
Verma, A.
Pappert, E. J.
Fernandez, H. H.
MOVEMENT DISORDERS, 2012, 27 : S348 - S349
[6] XCiDaBLE: A Phase 4, Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Preliminary Baseline Disease Severity and Quality of Life Data
LeDoux, Mark
Lin, Daniel
Jankovic, Joseph
Pappert, Eric
Verma, Amit
Sethi, Kapil
Fernandez, Hubert
NEUROLOGY, 2012, 78
[7] XCiDaBLE: An Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Interim Results from the First 145 Subjects with Cervical Dystonia
Fernandez, Hubert
Pagan, Fernando
Danisi, Fabio
Greeley, David
Jankovic, Joseph
Verma, Amit
Sethi, Kapil
Pappert, Eric
NEUROLOGY, 2013, 80
[8] A Prospective, Observational Trial Evaluating Xeomin [IncobotulinumtoxinA] for Cervical Dystonia (CD) or Blepharospasm in the United States - Preliminary Baseline Results for Patients with CD
Truong, Daniel D.
Danisi, Fabio O.
Sethi, Kapil D.
Verma, Amit
Pappert, Eric J.
Fernandez, Hubert H.
ANNALS OF NEUROLOGY, 2012, 72 : S103 - S103
[9] XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results for patients with CD
Truong, D.
Danisi, F.
Sethi, K.
Verma, A.
Pappert, E. J.
Fernandez, H. H.
MOVEMENT DISORDERS, 2012, 27 : S368 - S369
[10] Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm
Fernandez, Hubert H.
Jankovic, Joseph
Holds, John B.
Lin, Daniel
Burns, John
Verma, Amit
Sethi, Kapil
Pappert, Eric J.
TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2014, 4

← 1 2 3 →